Allovir Inc
Change company Symbol lookup
Select an option...
ALVR Allovir Inc
APAM Artisan Partners Asset Management Inc
ELEMF Elemental Altus Royalties Corp
FBSI First Bancshares Inc (Missouri)
KGDEY Kingdee International Software Group Co Ltd
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
Go

Health Care : Biotechnology |
Company profile

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to restore immunity in patients with T cell deficiencies. Its product candidate includes Viralym-M (ALVR105), ALVR106, ALVR109, ALVR107 and ALVR108. Its lead product candidate, Viralym-M, is a multi- VST therapy targeting five viruses: BK virus (BKV), cytomegalovirus (CMV), adenovirus (AdV), Epstein-Barr virus (EBV), and human herpesvirus 6 (HHV-6). The ALVR106 is an allogeneic VST therapy developed to target diseases caused by four respiratory viruses: respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). VST manufacturing platform enables the reproducible generation of single-virus and multi-virus specific cell therapeutic candidates.

Price
Delayed
$8.56
Day's Change
-0.20 (-2.28%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.93
Day's Low
8.22
Volume
(Light)

Today's volume of 121,318 shares is on pace to be much lighter than ALVR's 10-day average volume of 350,473 shares.

121,318
  • Prev Close
    8.76
  • Today's Open
    8.66
  • Day's Range
    8.22-8.93
  • Avg Vol (10-day)
    350.5K
  • Last (time)
    3:10p ET 10/05/22
  • Last (size)
    100
  • 52-Wk Range
    3.17 - 25.06
    LowHigh
  • (10/25/21 - 06/16/22)
    170.03%
  • 100.5%
  • Market Cap
    798.5M
  • Shares Outstanding
    93.1M
  • -3.02
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 33.67
  • (% of float 09/15/22)
    9.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.